8.60
8.60 (0%)
As of Apr 17, 2025
Arvinas Inc [ARVN]
Source:
Company Overview
Arvinas, Inc is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases.
| Country | United States |
| Headquarters | new haven, connecticut |
| Phone Number | (203) 535-1456 |
| Industry | manufacturing |
| CEO | John Houston, Ph.D. |
| Website | www.arvinas.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $263.4 |
| Operating Profit | $-250.2 |
| Net Income | $-198.9 |
| Net Cash | $-216.7 |
Profit Ratios
| Gross Margin | $263.4 |
| Operating Margin | -95 |
| Profit as % of Revenues | -132.4% |
| Profit as % of Assets | -16.6% |
| Profit as % of Stockholder Equity | -35.4% |
Management Effectiveness
| Return on Equity | -35.4% |
| Return on Assets | -18.2% |
| Turnover Ratio | 22% |
| EBITA | $-250.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,091.4 |
| Total Liabilities | $529.7 |
| Operating Cash Flow | $-259.3 |
| Investing Cash Flow | $34.7 |
| Financing Cash Flow | $7.9 |
